SPK-8011QQ for hemophilia a

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Nov 2025: Trial registered, NCT07226206
  2. 8 Sep 2026: Trial started, NCT07226206

The trials

NCT07226206: A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

State
Under way
Phase
Phase 1 and Phase 2
People
5 planned
Started
8 Sep 2026
Primary completion
30 Apr 2032
Arms
SPK-8011QQ
Results
None posted
  1. 10 Nov 2025: Trial registered
  2. 8 Sep 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.